Shared decision-making reaches stroke care, but the evidence base remains thin
Shared decision-making in stroke care is no longer confined to theory. A BMJ Open scoping review mapped how the approach has been used across acute treatment, secondary prevention and discharge planning, and found a field that is active but unevenly built. Seventeen studies met the inclusion criteria, with implementations ranging from paper tools to web-based platforms and computer-assisted systems.
The appeal is easy to understand at the bedside. Stroke decisions often must be made under time pressure, with incomplete recovery trajectories and consequences that may alter function, independence and long-term risk. In that setting, integrating clinical evidence with patient values is not a soft add-on; it is often the only practical way to align treatment with what matters to the person in front of the team.
Acute thrombolysis, prevention and discharge planning all entered the same review
The included studies were not confined to a single phase of care. Shared decision-making appeared in acute thrombolysis, secondary prevention and discharge planning, which tells a useful story about where the model has been tried and where it is still being assembled. Acute reperfusion decisions require rapid appraisal of benefits and hemorrhagic risk. Secondary prevention asks patients to weigh medications, adherence burden and lifestyle change against recurrent vascular risk. Discharge planning adds a different layer, where rehabilitation needs, caregiver capacity and follow-up logistics shape the next steps after hospitalization.
A one-size-fits-all workflow does not fit stroke. The decision points differ sharply across the care continuum, and the review shows that implementation followed that same fragmentation rather than a unified standard.
Decision aids varied more than the decisions themselves
Implementation formats were heterogeneous. Paper-based tools, visual decision aids, web-based platforms and computer-assisted systems all appeared in the literature, suggesting that investigators have been experimenting with delivery mode as much as with content. The underlying concept stayed constant: improve the quality of the conversation by giving patients a structured way to understand options, risks and preferences.
The diversity of tools matters because stroke is not a single decision event. Some patients are deciding about urgent thrombolysis, while others are choosing among preventive strategies or planning the transition home. Different formats may suit different clinical moments, but the review shows no settled consensus on which format works best, for whom, or in what care setting.
Digital tools may offer speed and consistency, yet they also depend on workflow, literacy, clinician buy-in and the patient’s ability to engage during a vulnerable period. Paper aids can be simpler to deploy, but they may be limited when information needs are complex or when staff need integrated prompts and documentation support.
Patient factors, clinician engagement and organizational friction shaped implementation
Influencing factors appeared at multiple levels. Patient-related factors affected how easily people could participate in decisions. Healthcare professional engagement influenced whether the conversation actually happened. The design and usability of the decision-support tools shaped how usable they were in real practice. Organizational processes determined whether SDM could be embedded or remained an isolated project.
These layers are not independent. A patient with communication deficits after stroke may need more time, adapted language or caregiver involvement. A clinician under acute workflow pressure may default to directive counseling unless the process is simple and well supported. An organization without clear pathways for documentation, training and follow-up can turn even a strong tool into a short-lived pilot.
This is where stroke exposes the limits of abstract enthusiasm. The same intervention can look straightforward in a protocol and awkward in routine care when the patient is fatigued, aphasic, anxious or clinically unstable. Implementation succeeds only when the tool matches the pace and cognitive demands of the moment.
The review found promise, but not yet a mature evidence base
Overall, the mapped literature suggested that SDM can improve patient involvement and decision quality. The signal is encouraging, but the evidence was still described as heterogeneous and limited. That combination makes the field interesting and unfinished at the same time. The review did not describe a large, consistent set of high-quality evaluations that would settle questions about effectiveness across all stroke contexts.
Variation in terminology is part of the problem. When studies define SDM differently, measure different outcomes, and test different delivery systems, the literature becomes difficult to compare. One project may focus on patient knowledge, another on satisfaction, another on decisional conflict, and another on clinician adherence to a structured conversation. Without common endpoints, even positive findings are hard to aggregate into practice guidance.
The review also points to a broader clinical reality: stroke care is highly time-sensitive, but shared decision-making depends on clarity, repetition and comprehension. Those forces can collide in acute care unless the process is designed with the realities of neurologic impairment and hospital workflow in mind.
Standard definitions and outcome measures remain the next bottleneck
The authors call for standardised definitions and outcome measures for SDM, along with decision-support tools that can be adapted to diverse stroke care processes. That request is practical. A field cannot mature when every study measures a different version of the same idea. Standardisation would make it easier to identify which intervention elements are essential, which are optional and which are ineffective.
Future work also needs to evaluate SDM across the full continuum of care rather than in isolated fragments. Acute treatment, prevention and discharge planning are clinically linked, yet the evidence base currently treats them as separate experiments. A coherent model would need to travel with the patient from emergency decision-making to secondary prevention and transition planning without losing fidelity.
The remaining gap is not whether shared decision-making sounds reasonable. It does. The gap is whether stroke services can operationalize it consistently enough to show durable benefit across settings, languages, levels of disability and the full sequence of decisions that follow a stroke event.
For now, the review leaves stroke care with a clear but incomplete message: shared decision-making is being used, patients can benefit from it, and the field still lacks the standardization and high-quality evaluation needed before it can be treated as routine everywhere.